Interleukin-2 and ovarian hyperstimulation syndrome: A pilot study

Human Reproduction

Volumn 10, Issue 1, 1995, Pages 24-27

  Orvieto, R ^a   Voliovitch, I ^a   Fishman, P ^b   Ben rafael, Z ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Cytokines; Interleukin 2; Ovarian hyperstimulation syndrome; Pathogenesis; Prediction

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; INTERLEUKIN 2; PROTEIN; TRIPTORELIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; GENITAL SYSTEM; HUMAN; IMMUNE SYSTEM; INFERTILITY; OOCYTE; OSMOLALITY; OVARY DISEASE; OVARY FOLLICLE FLUID; PATHOGENESIS;

EID: 0028909187     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/10.1.24     Document Type: Article

References (14)

1. Aboulghar, M.A., Mansour, R.T., Serour, G.I., Sattar, M.A., Amin, Y.M. and Elattar, br / L. (1993) Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy. Obstet. Gynecol., 81, 108-111.
2. Barak, V., Mordel, N., Zajicek, G., Kalichman, L., Treves, A.J. and Läufer, N. (1992) The correlation between interleukin 2 and soluble interleukin 2 receptors to oestradiol, progesterone and testosterone levels in periovulatory follicles of in-vitro fertilization patients. Hum. Reprod., 1, 926-929.
3. Ben Rafael, Z. and Orvieto, R. (1992) Cytokines—involvement in reproduction. Fertil. Steril., 58, 1093-1099.
4. Feinberg, B.B., Tan, N.S., Gonik, B., Brath, P.C. and Walsh, S.W. (1991) Increased progesterone concentrations are necessary to suppress interieukin-2-activated human mononuclear cell cytotoxicity. Am. J. Obstet. Gynecol., 165, 1872-1876.
5. Golan, A., Ron El, R., Herman, A., Soffer, Y., Weinraub, Z. and Caspi, E. (1989) Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv., 44, 430-440.
6. Laufer, N., Tarlatzis, B., DeChemey, A.H., Masters, L.T., Haseltine, F.P., MacLusky, N. and Naftolin, F. (1984) Asynchrony between human cumulus—corona cell complex (CCC) and oocyte maturation after human menopausal gonadotropin (HMG) treatment for in vitro fertilization (TVF). Fertil. Steril., 42, 366-372.
7. MacDougall, M.J., Tan, S.L. and Jacobs, H.S. (1992) In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum. Reprod., 7, 597-600.
8. Navot, D., Bergh, P.A. and Läufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
9. Oppenheim, J.J., Ruscetti, F.W. and Faltynek, C. (1991) Cytokines. In Stites, D.P. and Terr, A.I. (eds), Basic and Clinical Immunology, 7th edn. Appleton and Lange, East Norwalk, CT, p. 78.
10. Polishuk, W. and Schenker, L. (1969) Ovarian overstimulation syndrome. Fertil. Steril., 20, 443-450.
11. Smith, K.A. (1988) lnterleukin-2: inception, impact, and implication. Science, 240, 1169-1176.
12. Wang, L. and Norman, R.L. (1992) Concentrations of immunoreactive interleukin-1 and interleukin-2 in human preovulatory follicular fluid. Hum. Reprod., 7, 147-150.
13. Yarali, H., Fleige Zahraka, B.G., Yuen, B.H. and McComb, P.F. (1993) The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary. Fertil. Steril., 59, 657-661.
14. Zolti, M., Ben Rafael, Z., Meirom, R., Shemesh, M., Bider, D., Mashiach, S. and Apte, R.N. (1991) Cytokine involvement in oocytes and early embryos. Fertil. Steril., 56, 265-272.